24 results for “cannabis-europa”
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
France’s incoming generalised medical cannabis framework has edged closer to clearing its last remaining hurdle.
France’s medical cannabis experiment showed treatment was effective in reducing opioid use across four indications.
The development puts VER-01 in prime position to become the first FDA-approved cannabis-derived medicine for pain.
Clinicians, scientists and patients explored whether medical cannabis could help address longstanding inequalities in women’s health.
Medical cannabis patients are often framed as consumers chasing the next strain, but that overlooks how many navigate treatment, writes Dave Barton.
The former heavyweight boxing contender revealed he is using prescribed medical cannabis to manage chronic pain.
A new policy model aims to integrate women’s health conditions into medical cannabis frameworks across Europe.
More than 70 international speakers and over 1000 delegates are set to convene on London next month for policy debates, high-level networking, and the 2026 Business of Cannabis Awards.
Cannabis Europa panellist and Grow Group’s Managing Director, Pierre van Weperen, on the current state of play, and the future of cannabis-based medicine in the UK.
Cannaray Limited, its medical cannabis subsidiary Therismos, and Canadian ‘aquaponics’ cannabis cultivator Aqualitas are set to merge to create a new international vertically integrated cannabis company. Officially launching at Cannabis […]
The first domestically grown medical cannabis is now available to patients in the UK.
Scientists at 113 Botanicals and the University of Sussex are developing new formulations for cannabis-based medicines.
The UK’s first international prescribing service has launched for medical cannabis patients travelling to the country from overseas.
Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent.
Greek Health Minister to speak at Cannabis Europa London on Greece’s groundbreaking new medical cannabis programme, joined by Curaleaf executive chairman, Boris Jordan, and former Wimbledon champion, Pat Cash. Cannabis […]
Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner for Cannabis Europa, scheduled to take place in London on 25-26 June, 2024. Cannabis Europa is […]
A new review has identified ‘multiple lines of evidence’ to support the use of cannabis-based medicines in Long Covid.
Three experts unpick what we really know – and what we don’t.
One of Europe’s leading cannabis researchers on the importance of real-world data in drug development.
Experts say allowing GPs to initiate cannabis prescriptions would open up access in the UK.
How the female-led brand is tackling the huge unmet need in women’s healthcare through research and development.
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
Women, particularly women of colour, are woefully underrepresented in leadership positions across industries—cannabis can do better, and benefit.
